bg
P

Phathom Pharma (PHAT)

$000.00 0.00% ($0.00)

  • Today
  • Week
  • Month
  • Year
  • 5 Year
  • YTD
barakagetbaraka.com

About Phathom Pharma (PHAT)

Phathom Pharmaceuticals, Inc. is a late clinical-stage biopharmaceutical company. The Company is focused on developing and commercializing treatments for gastrointestinal (GI) diseases. Its product candidate, vonoprazan, is an oral small molecule pot... Read more

  • USD11.14
  • USD11.22
  • USD10.58
  • USD17.02
  • 8.90%
  • 1M
  • 178.15k
  • 810.26k
  • 644M
  • 6.07
  • 65.40%

Unlock More Stock Analysis & Reports

Access detailed stock analysis from LSEG including analyst price target estimates.